Ferguson Wellman Capital Management Inc. Sells 644 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Ferguson Wellman Capital Management Inc. trimmed its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 12.0% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,729 shares of the company’s stock after selling 644 shares during the quarter. Ferguson Wellman Capital Management Inc.’s holdings in GE HealthCare Technologies were worth $444,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Quent Capital LLC increased its position in GE HealthCare Technologies by 18.4% during the 3rd quarter. Quent Capital LLC now owns 766 shares of the company’s stock worth $72,000 after buying an additional 119 shares during the period. EverSource Wealth Advisors LLC increased its position in GE HealthCare Technologies by 8.7% during the second quarter. EverSource Wealth Advisors LLC now owns 1,590 shares of the company’s stock worth $135,000 after acquiring an additional 127 shares during the period. Quarry LP raised its stake in GE HealthCare Technologies by 28.3% in the 2nd quarter. Quarry LP now owns 594 shares of the company’s stock worth $46,000 after purchasing an additional 131 shares in the last quarter. Tempus Wealth Planning LLC boosted its holdings in GE HealthCare Technologies by 0.5% in the 2nd quarter. Tempus Wealth Planning LLC now owns 30,892 shares of the company’s stock valued at $2,407,000 after purchasing an additional 141 shares during the period. Finally, Little House Capital LLC grew its position in shares of GE HealthCare Technologies by 1.8% during the 2nd quarter. Little House Capital LLC now owns 8,074 shares of the company’s stock worth $629,000 after purchasing an additional 141 shares in the last quarter. 82.06% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, CEO Thomas J. Westrick sold 2,750 shares of the stock in a transaction on Wednesday, August 7th. The shares were sold at an average price of $80.78, for a total transaction of $222,145.00. Following the completion of the sale, the chief executive officer now directly owns 17,509 shares in the company, valued at $1,414,377.02. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Company insiders own 0.27% of the company’s stock.

Analyst Upgrades and Downgrades

GEHC has been the subject of several analyst reports. BTIG Research raised GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price objective for the company in a report on Wednesday, September 18th. JPMorgan Chase & Co. started coverage on GE HealthCare Technologies in a research note on Monday, September 9th. They issued a “neutral” rating and a $90.00 price target for the company. UBS Group downgraded shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and reduced their price objective for the stock from $84.00 to $74.00 in a research note on Thursday, September 26th. Evercore ISI boosted their target price on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the company an “outperform” rating in a research report on Tuesday, October 1st. Finally, Stifel Nicolaus upped their price target on shares of GE HealthCare Technologies from $100.00 to $102.00 and gave the stock a “buy” rating in a report on Monday, September 30th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, GE HealthCare Technologies presently has an average rating of “Moderate Buy” and a consensus price target of $94.23.

GE HealthCare Technologies Stock Up 0.6 %

NASDAQ:GEHC opened at $91.34 on Friday. GE HealthCare Technologies Inc. has a one year low of $62.35 and a one year high of $94.55. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.06 and a quick ratio of 0.82. The company has a market cap of $41.69 billion, a PE ratio of 26.71, a P/E/G ratio of 3.39 and a beta of 1.18. The firm’s 50 day simple moving average is $87.91 and its 200 day simple moving average is $83.39.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, July 31st. The company reported $1.00 EPS for the quarter, topping analysts’ consensus estimates of $0.98 by $0.02. The company had revenue of $4.84 billion for the quarter, compared to analyst estimates of $4.88 billion. GE HealthCare Technologies had a net margin of 8.10% and a return on equity of 25.26%. GE HealthCare Technologies’s revenue was up .5% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.92 earnings per share. On average, research analysts anticipate that GE HealthCare Technologies Inc. will post 4.26 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be given a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a yield of 0.13%. The ex-dividend date of this dividend is Friday, October 18th. GE HealthCare Technologies’s dividend payout ratio is presently 3.51%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.